Home
About
Overview
Sharing Data
ORCID
Help
History (7)
Health-Related Quality of Life Outcomes With Tofacitinib Treatment in Patients With Ulcerative Colitis in the Open-Label Extension Study, OCTAVE Open
The outstanding questions in transplantation: It's about time….
Trefoil Factor-1
Budesonide Foam Has a Favorable Safety Profile for Inducing Remission in Mild-to-Moderate Ulcerative Proctitis or Proctosigmoiditis.
Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn's Disease.
See All 7 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn's Disease.
Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn's Disease. Gastroenterology. 2018 07; 155(1):76-87.
View in:
PubMed
subject areas
Constriction, Pathologic
Crohn Disease
Delphi Technique
Endoscopy, Digestive System
Fibrosis
Humans
Intestines
authors with profiles
David Rubin